CRISPR Therapeutics (CRSP) PT Raised to $45 at TD Cowen

February 13, 2026 9:54 AM EST
Get Alerts CRSP Hot Sheet
Price: $56.82 -0.28%

Rating Summary:
    19 Buy, 14 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
TD Cowen analyst Tyler Van Buren raised the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $45.00 (from $40.00) while maintaining a rating.

You May Also Be Interested In





Related Categories

Analyst PT Change